Villa Medical Center Phuket (www.thailandstemcell.com), a forefront player in regenerative therapies and a key subsidiary of Atlantis Bioscience Singapore, proudly co-hosted the prestigious International Cell & Tissue Conference (ICTC) in Bangkok, Thailand. This global forum brought together scientists, clinicians, and thought leaders from the regenerative medicine community to share innovations, present research, and advance the clinical landscape of stem cell and tissue-based therapies.
Co-hosting the ICTC reinforces Villa Medical Center Phuket’ commitment to positioning Thailand as a world-class destination for safe, effective, and scientifically validated stem cell therapy under its Center of Excellence initiative.
A Premier Forum for Stem Cell and Tissue Science
The ICTC provided a full day of expert-led presentations and scientific exchange, highlighting the transformative power of cell and tissue-based therapies in both human and veterinary medicine. It featured insights into translational research, clinical case studies, and cutting-edge biomedical technologies that are driving innovation in the regenerative sector.
The event was inaugurated by Dr. Chutima Eamchotchawalit, Governor of the Thailand Institute of Scientific and Technological Research (TISTR), who emphasized the need for collaboration and scientific transparency in the pursuit of advanced biomedical solutions. Her speech underscored Thailand’s momentum as a regional hub for biotechnology and therapeutic development.
Associate Professor Too Heng Phon of the National University of Singapore delivered the keynote address, outlining the safety and precision of non-viral gene editing in mesenchymal stem cells (MSCs). He described the transition from laboratory research to clinical use, showcasing how engineered MSCs can offer safer, more targeted outcomes in patient care.
Expanding Stem Cell Applications to Veterinary Science
A highlight of the conference came from Dr. Ruttachuk Rungsiwiwutt of Srinakharinwirot University, who presented breakthrough work in applying MSCs to manage chronic conditions and joint deterioration in animals. His research drew compelling parallels between stem cell benefits in human and veterinary medicine, emphasizing the cross-disciplinary relevance of regenerative technologies.
This segment expanded the conversation around the scope of stem cell therapy, reminding attendees of its multi-species applications and the universal need for innovative treatment modalities.
Pioneering Topics: CRISPR, CAR-T, and Artificial Intelligence
Afternoon sessions explored leading-edge research in biomedical sciences. Dr. Jungjoon Kempthorne Lee introduced extra-seq technology to evaluate CRISPR off-target effects in stem cells, a key advancement in ensuring the precision and safety of gene-edited therapies.
Dr. Sun Hongyan of GemPharmaTech shared data on CAR-T cell therapy development, with a focus on robust non-clinical testing protocols designed to meet the challenges of treating complex cancers. Meanwhile, Dr. Jennifer Dodgson of Kipley AI, Singapore, demonstrated the application of artificial intelligence in tailoring regenerative treatments and accelerating clinical trial design, offering a vision of personalized medicine empowered by data-driven tools.
Thailand’s Strategic Position in Medical Tourism and Regenerative Investment
The conference also highlighted Thailand’s growing profile as a hub for medical tourism and regenerative innovation. Dr. Gary Lim, an authority in naturopathic medicine, led a discussion on Thailand’s competitive advantages cutting-edge facilities, cost-effective treatments, and a high safety standard for cellular therapies.
These sessions emphasized Thailand’s readiness to attract global patients and investors, further boosted by a proactive regulatory framework and a skilled biomedical workforce.
Villa Medical Center Phuket: Leading the Way as a Center of Excellence
As an active co-host of ICTC, Villa Medical Center Phuket reasserted its leadership in cell-based therapy and regenerative science. Through its Center of Excellence program, the organization provides:
– High-quality mesenchymal stem cells sourced and expanded under GMP conditions
– Personalized treatment programs for conditions such as osteoarthritis, metabolic disorders, autoimmune diseases, and age-related decline
– Ongoing collaborations with academic and clinical institutions across Asia-Pacific
– A commitment to educational outreach and international scientific dialogue
These initiatives are central to Atlantis’s mission of delivering safe, science-backed therapies grounded in rigorous testing and ethical sourcing.
About Villa Medical Center Phuket
Villa Medical Center Phuket is a Thailand-based provider of advanced stem cell and regenerative medicine solutions. Backed by Atlantis Bioscience Singapore, the company specializes in mesenchymal stem cell therapies tailored to support healing, immune modulation, and tissue regeneration. Atlantis operates with strict adherence to international quality standards and collaborates with institutions worldwide to push the boundaries of cellular medicine.
The ICTC co-hosting event marks yet another step in Atlantis’s ongoing mission to elevate the standards of regenerative care, research, and innovation not only in Thailand but across the broader Southeast Asian region.
Villa Medical Center Phuket
Villa Sukhothai, Soi Pasak 8, Choeng Thale,
Thalang District, Phuket, Thailand
Email: atlantisphuket@gmail.com
Phone/WhatsApp: +66 99 301 6969